Skip to content

Study Evaluating Retinal Health Monitoring System Thickness Module

Evaluation of the Retinal Health Monitoring System - Retinal Thickness Module in Subjects With Normal Macular Thickness and Subjects With Center-involving Macular Edema

Status
Withdrawn
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04428242
Enrollment
0
Registered
2020-06-11
Start date
2020-04-30
Completion date
2020-07-31
Last updated
2021-02-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Macular Edema, Macular Degeneration

Keywords

Macular Edema, Wet AMD, Retinal Thickness, Diabetic Retinopathy, Retinal Vein Occlusion

Brief summary

Evaluate the ability and accuracy of the Retinal Health Monitoring System - Retinal Thickness Module (RHMS - RTM).

Detailed description

Evaluation of the Retinal Health Monitoring System - Retinal Thickness Module in subjects with normal macular thickness and subjects with center-involving macular edema.

Interventions

DEVICERHMS-RTM

Assessment of retinal thickness.

DIAGNOSTIC_TESTSD-OCT

Assessment of retinal structure.

Sponsors

Kubota Vision Inc.
Lead SponsorINDUSTRY

Study design

Observational model
OTHER
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

1. Corrected visual acuity (VA) of 20/100 or better, in the study eye(s) 2. Media clarity, undilated pupil size, OCT-B scans, axial length measurements in the study eye(s) 3. Able to perform self-testing of retinal thickness with the RHMS-RTM after training 4. Able and willing to give informed consent 5. Group 1: 1. Macula with normal thickness \[central subfield thickness (CST) below 305 microns as measured by SD-OCT\] in at least one eye 2. Patients with dry AMD are eligible for enrollment into Group 1 3. No history of wet AMD, DR, or RVO in either eye 6. Group 2 and Group 3 (in at least one or the same eye): 1. History of center-involving macular edema due to wet AMD (Group 2); or DR or RVO (Group 3) 2. Macular edema on SD-OCT with CST ≥ 305 microns

Exclusion criteria

1. History of corneal refractive surgery, photorefractive keratectomy, radial keratotomy, in the study eye 2. History of epiretinal membrane, vitreomacular traction, or macular hole in the study eye(s) 3. Participation in any study using an investigational drug within 30 days or screening or investigational device within 60 days of screening 4. Refractive error: spherical equivalent of \> 3 diopters of hyperopia or \> 6 diopters of myopia, or \> 2 diopters cylinder in the study eye(s) 5. History of photocoagulation laser scar or other retinal scar in the central 3 mm of the macula, in the study eye(s)

Design outcomes

Primary

MeasureTime frameDescription
Evaluation of the RHMS-RTM retinal thickness measurements1 dayTo evaluate the ability of the RHMS-RTM device to measure retinal thickness
RHMS-RTM repeatability1 dayTo assess repeatability of the RHMS-RTM device
Comparison of retinal thickness measurements between the RHMS-RTM and the SD-OCT1 monthTo evaluate the agreement of measurements by the RHMS-RTM and SD-OCT

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026